Bertrand Lebouché

3.5k total citations · 2 hit papers
142 papers, 1.9k citations indexed

About

Bertrand Lebouché is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Bertrand Lebouché has authored 142 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Infectious Diseases, 65 papers in Epidemiology and 38 papers in General Health Professions. Recurrent topics in Bertrand Lebouché's work include HIV/AIDS Research and Interventions (69 papers), HIV, Drug Use, Sexual Risk (37 papers) and HIV-related health complications and treatments (24 papers). Bertrand Lebouché is often cited by papers focused on HIV/AIDS Research and Interventions (69 papers), HIV, Drug Use, Sexual Risk (37 papers) and HIV-related health complications and treatments (24 papers). Bertrand Lebouché collaborates with scholars based in Canada, United States and France. Bertrand Lebouché's co-authors include Kim Engler, David Lessard, Jean‐Pierre Routy, Marina B. Klein, Joseph Cox, Giada Sebastiani, Marie‐Pascale Pomey, Cecilia T. Costiniuk, Nadine Kronfli and Réjean Thomas and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Bertrand Lebouché

131 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic

2022 94 citations Bertrand Lebouché, Marie‐Pascale Pomey et al. Healthcare profile →
Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review

2024 73 citations Moustafa Laymouna, Yuanchao Ma et al. profile →

Peers

Countries citing papers authored by Bertrand Lebouché

Since Specialization

Citations

This map shows the geographic impact of Bertrand Lebouché's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Lebouché with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Lebouché more than expected).

Fields of papers citing papers by Bertrand Lebouché

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Lebouché. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Lebouché. The network helps show where Bertrand Lebouché may publish in the future.

Co-authorship network of co-authors of Bertrand Lebouché

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Lebouché. A scholar is included among the top collaborators of Bertrand Lebouché based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Lebouché. Bertrand Lebouché is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship Breakup Impact on Mental Health and Safer Sex Among Men Who Have Sex with Men in the United Kingdom 2025 ·Journal of Homosexuality ·(unknown), Kim Engler, Bertrand Lebouché, Ford Hickson	0
2	Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity 2024 ·Frontiers in Immunology ·(unknown), Léna Royston, (unknown), Carolina Berini, Cécile Tremblay, Bertrand Lebouché, Joseph Cox, Cecilia T. Costiniuk, Madéleine Durand, Stéphane Isnard, Jean‐Pierre Routy	7
3	Material deprivation is associated with liver stiffness and liver‐related outcomes in people with HIV 2024 ·Liver International ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bertrand Lebouché, Nadine Kronfli, Joseph Cox, Cecilia T. Costiniuk, Alexandra de Pokomandy, Jean‐Pierre Routy, Marina B. Klein, (unknown), Ramanakumar V. Agnihotram, Sahar Saeed, Giada Sebastiani	1
4	Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge–Attitudes–Practices Survey 2024 ·Healthcare ·Moustafa Laymouna, Yuanchao Ma, David Lessard, Kim Engler, (unknown), Tibor Schuster, (unknown), Sofiane Achiche, (unknown), (unknown), (unknown), Bertrand Lebouché	1
5	Conceptions of sexual health by gay men living with HIV in serodifferent couples in Montreal, Canada: results from a qualitative analysis 2024 ·Sexual Health ·(unknown), Kim Engler, Joseph Cox, Ford Hickson, David Lessard, (unknown), Réjean Thomas, Bertrand Lebouché	0
6	Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada 2024 ·International Journal of Drug Policy ·Nadine Kronfli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Giada Sebastiani, Marina B. Klein, Bertrand Lebouché, Joseph Cox, Matthew J. Akiyama	3
7	Fibroscan–Aspartate Aminotransferase Score Predicts Liver-Related Outcomes, but Not Extrahepatic Events, in a Multicenter Cohort of People With Human Immunodeficiency Virus 2023 ·Clinical Infectious Diseases ·Giada Sebastiani, (unknown), (unknown), Claudia Gioè, (unknown), Bertrand Lebouché, Emmanuel Tsochatzis, (unknown), (unknown), Agnihotram V. Ramanakumar, Sanjay Bhagani, Amine Benmassaoud, Giovanni Mazzola, Antonio Cascio, Giovanni Guaraldi	10
8	Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort 2023 ·BMJ Open ·(unknown), Sahar Saeed, (unknown), (unknown), (unknown), Erica E. M. Moodie, Colleen Price, (unknown), Curtis Cooper, Sharon Walmsley, Neora Pick, Melanie C. M. Murray, Joseph Cox, Nadine Kronfli, Cecilia T. Costiniuk, Alexandra de Pokomandy, Jean‐Pierre Routy, Bertrand Lebouché, Marina B. Klein, Giada Sebastiani	4
9	Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial 2023 ·Cells ·Ralph‐Sydney Mboumba Bouassa, (unknown), (unknown), Amélie Pagliuzza, (unknown), Suzanne Samarani, Judy Needham, Joel Singer, Terry Lee, Florian Bobeuf, (unknown), Giada Sebastiani, Shari Margolese, (unknown), Marina B. Klein, Bertrand Lebouché, Jean‐Pierre Routy, Nicolas Chomont, Cecilia T. Costiniuk, Mohammad‐Ali Jenabian	11
10	Switch to a raltegravir‐based antiretroviral regimen in people with HIV and non‐alcoholic fatty liver disease: A randomized controlled trial 2023 ·HIV Medicine ·(unknown), Bertrand Lebouché, (unknown), Sahar Saeed, Agnihotram V. Ramanakumar, (unknown), Alexandra de Pokomandy, Joseph Cox, Cecilia T. Costiniuk, Jean‐Pierre Routy, Marina B. Klein, Giada Sebastiani	1
11	Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study 2023 ·BMJ Open ·Léna Royston, Stéphane Isnard, Carolina Berini, (unknown), Péter L. Lakatos, Talat Bessissow, Nicolas Chomont, Marina B. Klein, Bertrand Lebouché, Alexandra de Pokomandy, Nadine Kronfli, Cecilia T. Costiniuk, Réjean Thomas, Cécile Tremblay, Guy Boivin, Jean‐Pierre Routy	2
12	Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study) 2023 ·JMIR Research Protocols ·Yuanchao Ma, Sofiane Achiche, Marie‐Pascale Pomey, (unknown), (unknown), (unknown), Kim Engler, Moustafa Laymouna, David Lessard, (unknown), Jamil Asselah, (unknown), Esli Osmanlliu, (unknown), Yann Joly, Bertrand Lebouché	8
13	Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study) 2022 ·JMIR Research Protocols ·David Lessard, Kim Engler, Yuanchao Ma, (unknown), (unknown), Nadine Kronfli, Sapha Barkati, Marie‐Josée Brouillette, Joseph Cox, J. Kildea, Tarek Hijal, Marie‐Pascale Pomey, Susan J. Bartlett, Jamil Asselah, Bertrand Lebouché	0
14	Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The ‘ASAP’ Study 2022 ·Journal of Personalized Medicine ·Anish Arora, Kim Engler, David Lessard, Nadine Kronfli, (unknown), (unknown), (unknown), Jean‐Pierre Routy, (unknown), Joseph Cox, Alexandra de Pokomandy, (unknown), Marina B. Klein, Giada Sebastiani, Isabelle Vedel, Amélie Quesnel‐Vallée, Bertrand Lebouché	7
15	The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study 2022 ·Diagnostics ·Giada Sebastiani, (unknown), Cecilia T. Costiniuk, Joseph Cox, (unknown), Marina B. Klein, Nadine Kronfli, Jean‐Pierre Routy, Julian Falutz, Bertrand Lebouché, Giovanni Guaraldi	4
16	Development of a Prototype for a Bilingual Patient-Reported Outcome Measure of the Important Health Aspects of Quality of Life in People Living with HIV: The Preference Based HIV Index (PB-HIV) 2022 ·Journal of Personalized Medicine ·Kedar Mate, Bertrand Lebouché, Marie‐Josée Brouillette, Lesley K. Fellows, Nancy E. Mayo	1
17	Two-Tier Care Pathways for Liver Fibrosis Associated to Non-Alcoholic Fatty Liver Disease in HIV Mono-Infected Patients 2022 ·Journal of Personalized Medicine ·Giada Sebastiani, Jovana Milić, (unknown), Sahar Saeed, Thomas Krahn, (unknown), (unknown), Bertrand Lebouché, Philip Wong, Marc Deschênes, Claudia Gioè, Antonio Cascio, Giovanni Mazzola, Giovanni Guaraldi	1
18	Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review 2021 ·JMIR mhealth and uhealth ·(unknown), Kedar Mate, Kim Engler, (unknown), Marie‐Pascale Pomey, Joseph Cox, Tarek Hijal, Bertrand Lebouché	40
19	Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy 2020 ·SHILAP Revista de lepidopterología ·Bertrand Lebouché, (unknown), (unknown), Omar Farnós, Joel Singer, Ido P. Kema, Cecilia T. Costiniuk, Réjean Thomas, Marie‐Josée Brouillette, Kim Engler, Jean‐Pierre Routy, Mohammad‐Ali Jenabian, (unknown)	2
20	A Higher Frequency of NKG2A ⁺ than of NKG2A ⁻ NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1 2015 ·Journal of Virology ·(unknown), Gamze Isitman, Rujun Song, Sandrina DaFonseca, (unknown), Bertrand Lebouché, Jean‐Pierre Routy, Julie Bruneau, Nicole F. Bernard	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact